ArticleNature medicine2015

NY-ESO-1-specific TCR-engineered T cells mediate sustained antigen-specific antitumor effects in myeloma.

Aaron P Rapoport et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.